Lupin signs China deal for diabetes-weight loss drug

Lupin, a big medicine company, has made a special deal with Gan & Lee in China.

They will work together on a medicine called Bofanglutide.

This medicine helps people with a type of diabetes called type 2 and also helps them manage their weight.

Lupin is also in the process of acquiring VISUfarma, a company based in Amsterdam, which is expected to be completed by February 28, 2026.

The market reaction to Lupin's shares has been mixed, with a slight decline following the announcement of the deal.

This deal is important because it helps Lupin grow its business in helping people with diabetes and weight issues.